ARTICLE SUMMARY:
Medtechs angle for a big slice of the multibillion-dollar migraine market; Acutus Medical’s strategy for building a pure play in electrophysiology; IDbyDNA aims to revolutionize infectious disease testing through metagenomics; Healyx Labs advances affordable wound care; Is the paclitaxel drug-coated device controversy over? These stories and more in the current issue of MedTech Strategist.
